Milestones 2004
Complete ARQ 501 phase I recruitment
Initiate Phase 1b clinical trials for ARQ 501
Progress 2nd generation E2F programs towards IND filing
Complete ARQ-101 outlicensing assessment
Meet Chemistry Technologies Revenue Goal
Previous slide
Next slide
Back to first slide
View graphic version